background tested intermediate mz sz severe zz deficiency affects lung function population large methods performed spirometry forced expiratory volume NUMBER s fev1 forced vital capacity fvc genotyping NUMBER individuals adult general population copenhagen denmark results expected frequencies individuals mm ms ss mz sz zz genotypes NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER respectively genotype interacted clinically established chronic obstructive pulmonary disease copd percentage predicted fev1 p NUMBER NUMBER percentage predicted fev1 reduced mz compared mm individuals clinically established copd copd furthermore sz compound heterozygotes lower ratios mm individuals p NUMBER zz homozygotes lower percentages predicted fev1 ratios mm ms ss mz individuals ps NUMBER reduced lung function sz zz vs mm individuals demonstrated current nonsmokers compared mm individuals groups fev1 reduced NUMBER ml mz individuals clinically established copd NUMBER ml sz current smokers NUMBER ml zz current smokers conclusions population large mz associated reduced pulmonary function individuals clinically established copd sz zz associated reduced pulmonary function smokers presence mz genotype certain circumstances produce marked aggravation airway obstruction individuals prone develop copd alpha1 antitrypsin ex smokers alpha1 antitrypsin fev1 fvc fev1 fvc